Showing results (131-140 of 166) with videos related to
Sort By:
Pageof 17
British Journal of Cancer|February 7, 2013
Innovative estimation of survival using log-normal survival modelling on ACCENT databaseJ W Chapman, C J O'Callaghan, N Hu, et al.Oncogene|November 22, 2016
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signalingX Tang, C-K Ding, J Wu, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|June 16, 2018
Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786)E Vigneault, G Morton, W R Parulekar, et al.Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|March 2, 2026
[Role of intraoperative neurophysiological monitoring in high-risk endovascular aortic repair for spinal cord ischemia]C K Ding, Y J Lu, X G Zhang, et al.Clinical and Experimental Immunology|April 16, 2014
Distinguishing immunorelated haemocytopenia from idiopathic cytopenia of undetermined significance (ICUS): a bone marrow abnormality mediated by autoantibodiesR Fu, H Liu, Y Wang, et al.Arthritis Research & Therapy|December 12, 2018
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 studyL C Coates, D D Gladman, P Nash, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphomaD A Macdonald, K Ding, M K Gospodarowicz, et al.The Journal of Biological Chemistry|June 10, 2000
Mutant presenilin 2 transgenic mice. A large increase in the levels of Abeta 42 is presumably associated with the low density membrane domain that contains decreased levels of glycerophospholipids and sphingomyelinN Sawamura, M Morishima-Kawashima, H Waki, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2010
Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24R Goodwin, K Ding, L Seymour, et al.Physical Review. E|March 16, 2024
Dynamic stabilization of ablative Rayleigh-Taylor instability in the presence of a temporally modulated laser pulseK G Zhao, Z Y Li, L F Wang, et al.Pageof 17